News
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...
Aktiia, a pioneer in continuous blood pressure monitoring, has secured FDA 510(k) clearance for its medical-grade G0 Blood ...
South Carolina cooks may want to be extra cautious when cooking meat after considering a new report that showed more than a ...
Researchers from the University of Georgia found a new drug that may boost the brain's ability to heal itself after injury.
Some Ritz peanut butter cracker sandwiches are being recalled because the individually wrapped packs may be incorrectly ...
Shares of Evoke Pharma are trading sharply higher Wednesday morning. The specialty pharma company received a U.S. Patent ...
In what experts are calling a “dream come true,” scientists used a recent biochemical discovery to help an 8-year-old boy ...
Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...
Despite a certain amount of upheaval at the FDA, the agency has continued to keep up with its scheduled approvals and clearances. At BIO 2025, editor-in-chief Jonah Comstock sat down with Mursla Bio ...
LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, is pleased to announce ...
Molecules that build coenzyme Q10, vital for mitochondrial function, healed mice and a patient with an ultra-rare and lethal ...
The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results